Market Overview

UPDATE: Deutsche Bank Raises PT to $29 on Team Health on Revenue Visibility

Share:
Related TMH
Barclays Analyst Sees Sick Shifting From Hospitals To Outpatient Clinics
TeamHealth Acquires Premier Physician Services
Team Health Holdings: A Well-Run Company With Strong Growth Prospects (Seeking Alpha)

Deutsche Bank reiterated its Buy rating on Team Health (NYSE: TMH) and raised its price target from $26 to $29.

Deutsche Bank noted, "We expect another strong quarter, driven by top-line growth that should remain balanced b/w organic (same-contract), new contract sales and contributions from M&A. In light of strong rev growth visibility, we are raising our PT to $29 (from $26) and now put the fwd EV/EBITDA at the upper end of the group's historical 8x-9x range."

Team Health closed at $26.94 on Monday.

Latest Ratings for TMH

DateFirmActionFromTo
Jan 2015CitigroupDowngradesBuyNeutral
Sep 2014Stifel NicolausMaintainsBuy
Sep 2014Deutsche BankMaintainsHold

View More Analyst Ratings for TMH
View the Latest Analyst Ratings

Posted-In: Deutsche BankAnalyst Color Price Target Intraday Update Analyst Ratings

 

Related Articles (TMH)

Around the Web, We're Loving...

Get Benzinga's Newsletters